Patent & IP news archive

New England Biolabs, Inc. et. al.
v. Enzymatics, Inc.

Complaint for Declaratory Judgement
Civil Action No. 1:12-cv-12125; no judge yet assigned.
Filed on Nov. 14, 2012 in the U.S. District Court for the District of Massachusetts;

Plaintiffs

v.
Gilead Sciences
New England Biolabs
Choate, Hall & Stewart; Boston, MA
Michael H. Bunis

SomaLogic

Defendants

Enzymatics

Patents in case

  • 5,670,637: “Nucleic acid ligands” by Gold et. al. Prosecuted by Swanson & Bratschun, L.L.C.. Includes 8 claims (1 indep.). Was application 08/412,110. Granted 9/23/1997.
  • 5,874,557: “Nucleic acid ligand inhibitors to DNA polymerases” by Gold et. al. Prosecuted by Swanson & Bratschun LLC. Includes 6 claims (4 indep.). Was application 08/487,720. Granted 2/23/1999.

Attorney? Our daily litigation alerts are free, awesome, and include complaint PDFs.

Case documents (PDF)

Fig. 1 from 5,670,637

5,670,637 figure 1
Some content © 2007–2014 RPX Corporation.
Terms of service
Privacy policy
For DMCA requests contact help@priorsmart.com.